Significance of lymphovascular space invasion in epithelial ovarian cancer

Cancer Medicine

Volumn 1, Issue 2, 2012, Pages 156-164

  Matsuo, Koji ^a   Sheridan, Todd B ^b   Yoshino, Kiyoshi ^c   Miyake, Takahito ^c   Hew, Karina E ^b   Im, Dwight D ^b   Rosenshein, Neil B ^b   Mabuchi, Seiji ^c   Enomoto, Takayuki ^c   Kimura, Tadashi ^c   Sood, Anil K ^d,e   Roman, Lynda D ^a,f  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MERCY MEDICAL CENTER   (United States)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Lymph node metastasis; Lymphovascular space invasion; Ovarian cancer; Survival

Indexed keywords

ADVANCED CANCER; AORTIC LYMPHADENECTOMY; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PELVIS LYMPHADENECTOMY; POST HOC ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; VALIDATION STUDY;

EID: 84884539755     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.31     Document Type: Article

References (27)

1. Siegel, R., D. Naishadham, and A. Jemal. 2012. Cancer statistics, 2012. CA Cancer J. Clin. 62:10-29.
2. Hennessy, B. T., R. L. Coleman, and M. Markman. 2009. Ovarian cancer. Lancet 374:1371-1382.
3. Hachisuga, T., T. Kaku, K. Fukuda, F. Eguchi, M. Emoto, T. Kamura, et al. 1999. The grading of lymphovascular space invasion in endometrial carcinoma. Cancer 86:2090-2097.
4. O'Brien, D. J., G. Flannelly, E. E. Mooney, and M. Foley. 2009. Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality. BJOG 116:991-994.
5. Tsuruchi, N., T. Kaku, T. Kamura, N. Tsukamoto, M. Tsuneyoshi, K. Akazawa, et al. 1995. The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining. Gynecol. Oncol. 57:307-312.
6. Watanabe, Y., T. Satou, H. Nakai, T. Etoh, K. Dote, N. Fujinami, et al. 2010. Evaluation of parametrial spread in endometrial carcinoma. Obstet. Gynecol. 116:1027-1034.
7. Guntupalli, S. R., I. Zighelboim, N. T. Kizer, Q. Zhang, M. A. Powell, P. H. Thaker, et al. 2012. Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. Gynecol. Oncol. 124:31-35.
8. Sakuragi, N., N. Takeda, H. Hareyama, T. Fujimoto, Y. Todo, K. Okamoto, et al. 2000. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma. Cancer 88:2578-2583.
9. Morice, P., P. Piovesan, A. Rey, D. Atallah, C. Haie-Meder, P. Pautier, et al. 2003. Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma: results of a multivariate analysis. Ann. Oncol. 14:1511-1517.
10. Lim, C. S., F. Alexander-Sefre, M. Allam, N. Singh, J. C. Aleong, H. Al-Rawi, et al. 2008. Clinical value of immunohistochemically detected lymphovascular space invasion in early stage cervical carcinoma. Ann. Surg. Oncol. 15:2581-2588.
11. Memarzadeh, S., S. Natarajan, D. P. Dandade, N. Ostrzega, P. A. Saber, A. Busuttil, et al. 2003. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstet. Gynecol. 102:612-619.
12. Chernofsky, M. R., J. C. Felix, L. I. Muderspach, C. P. Morrow, W. Ye, S. G. Groshen, et al. 2006. Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol. Oncol. 100:288-293.
13. Roman, L. D., J. C. Felix, L. I. Muderspach, T. Varkey, A. F. Burnett, D. Qian, et al. 1998. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol. Oncol. 68:220-225.
14. Cheng, X., R. Zang, X. Wu, Z. Li, S. Cai, and Z. Zhang. 2009. Recurrence patterns and prognostic factors in Chinese patients with squamous cell carcinoma of the vulva treated with primary surgery. Int. J. Gynecol. Cancer 19:158-162.
15. Rouzier, R., M. Preti, B. Haddad, M. Martin, L. Micheletti, and B. J. Paniel. 2006. Development and validation of a nomogram for predicting outcome of patients with vulvar cancer. Obstet. Gynecol. 107:672-677.
16. Raspagliesi, F., F. Hanozet, A. Ditto, E. Solima, F. Zanaboni, F. Vecchione, et al. 2006. Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva. Gynecol. Oncol. 102:333-337.
17. O'Hanlan, K. A., S. Kargas, M. Schreiber, D. Burrs, P. Mallipeddi, T. Longacre, et al. 1995. Ovarian carcinoma metastases to gastrointestinal tract appear to spread like colon carcinoma: implications for surgical resection. Gynecol. Oncol. 59:200-206.
18. Qian, X., X. Xi, and Y. Jin. 2010. The grading of lymphovascular space invasion in epithelial ovarian carcinoma. Int. J. Gynecol. Cancer 20:895-899.
19. Matsuo, K., V. K. Bond, M. L. Eno, D. D. Im, and N. B. Rosenshein. 2009. Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer. Int. J. Cancer 125:2721-2727.
20. Bodurka, D. C., M. T. Deavers, C. Tian, C. C. Sun, A. Malpica, R. L. Coleman, et al. 2012. Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study. Cancer 118:3087-3094.
21. Malpica, A., M. T. Deavers, K. Lu, D. C. Bodurka, E. N. Atkinson, D. M. Gershenson, et al. 2004. Grading ovarian serous carcinoma using a two-tier system. Am. J. Surg. Pathol. 28:496-504.
22. Ariyoshi, K., S. Kawauchi, T. Kaku, H. Nakano, and M. Tsuneyoshi. 2000. Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases. Histopathology 37:427-436.
23. Fujimoto, T., N. Sakuragi, K. Okuyama, T. Fujino, K. Yamashita, S. Yamashiro, et al. 2001. Histopathological prognostic factors of adult granulosa cell tumors of the ovary. Acta Obstet. Gynecol. Scand. 80:1069-1074.
24. Nishimura, N., T. Hachisuga, M. Yokoyama, T. Iwasaka, and T. Kawarabayashi. 2005. Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary. J. Obstet. Gynaecol. Res. 31:120-126.
25. Spannuth, W. A., A. K. Sood, and R. L. Coleman. 2008. Angiogenesis as a strategic target for ovarian cancer therapy. Nat. Clin. Pract. Oncol. 5:194-204.
26. Botting, S. K., H. Fouad, K. Elwell, B. A. Rampy, S. A. Salama, D. H. Freeman, et al. 2010. Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor 3 in invasive squamous cell cervical cancer. Transl. Oncol. 3:170-175.
27. Lee, J. S., H. S. Kim, J. J. Jung, M. C. Lee, and C. S. Park. 2002. Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression. Gynecol. Oncol. 85:469-475.